 REDWOOD CITY, CA ACCESSWIRE January 6, 2021 Avinger, Inc. NASDAQ:AVGR, a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the diagnosis and treatment of Peripheral Artery Disease PAD, today announced that its executive team will participate in the H.C. Wainwright Bioconnect 2021 Conference taking place virtually January 11-14, 2021. 